2022
DOI: 10.1016/j.jddst.2022.103938
|View full text |Cite
|
Sign up to set email alerts
|

Nanomaterials loaded with Quercetin as an advanced tool for cancer treatment

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
9
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 29 publications
(9 citation statements)
references
References 112 publications
0
9
0
Order By: Relevance
“…These HDs were in the range regarded as optimal for in vivo applications (≈50 nm). [ 60 ] On the contrary, unexpectedly poor stability was noticed for both ZnFe1@Fe‐PEG and ZnFe2@Fe‐PEG, suggesting that the PEGylated ligand was not able to properly interact with the NPs surface, even though alloy NPs were mainly composed of Fe.…”
Section: Resultsmentioning
confidence: 99%
“…These HDs were in the range regarded as optimal for in vivo applications (≈50 nm). [ 60 ] On the contrary, unexpectedly poor stability was noticed for both ZnFe1@Fe‐PEG and ZnFe2@Fe‐PEG, suggesting that the PEGylated ligand was not able to properly interact with the NPs surface, even though alloy NPs were mainly composed of Fe.…”
Section: Resultsmentioning
confidence: 99%
“…Quercetin research within nanotechnology is promising due to its potential to enhance bioavailability and targeted delivery, overcoming traditional limitations like poor solubility and rapid metabolism [103]. Nanotechnology-based systems aim to optimize quercetin's therapeutic use by reducing dosage and minimizing side effects [104]. Additionally, quercetin is being investigated for its synergistic effects with other treatments, particularly in cancer therapy, to improve outcomes and reduce adverse effects by modulating key biological pathways [105,106].…”
Section: Section 4: Cutting-edge Advances In Quercetin Researchmentioning
confidence: 99%
“…The developed nanoformulations showed enhanced anti-tumour activity by controlling essential molecular pathways like cyclins, mitogen-activated protein kinase (MAPK) and PI3K/Akt. These formulations also showed synergistic effect in the cancer management by obstructing drug efflux regulated by transporter proteins and enhance the rate of apoptosis that ultimately results in death of cancerous cells [9]. Zinc oxide NPs were formulated for QCT targeted site delivery by Sadhukhan et al and the developed NPs resulted in increased apoptosis, destruction of breast carcinoma cells [10].…”
Section: Introductionmentioning
confidence: 99%